COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 717: Articles 7161-7170  | Next

Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for SARS-CoV-2 3CL Protease
Hirose, Y., Shindo, N., Mori, M., Onitsuka, S., Isogai, H., Hamada, R., Hiramoto, T., Ochi, J., Takahashi, D., Ueda, T., Caaveiro, J. M. M., Yoshida, Y., Ohdo, S., Matsunaga, N., Toba, S., Sasaki, M., Orba, Y., Sawa, H., Sato, A., Kawanishi, E., Ojida, A.
10.1101/2022.06.05.494897 — Posted: 2022-06-06
Cross-Cultural Adaptation and Validation of the 5C Scale to Identify Factors Associated With COVID-19 and Influenza Vaccine Hesitancy Among Healthcare Workers in Cape Town, South Africa - A Protocol
Alobwede, S. M., Katoto, P., Cooper, S., Lumngwena, E., Kidzeru, E., Goliath, R., Jackson, A., Wiysonge, C., Shey, M.
10.1101/2022.06.06.22276038 — Posted: 2022-06-06
Correlates of protection, thresholds of protection, and immunobridging in SARS-CoV-2 infection
Khoury, D. S., Schlub, T. E., Cromer, D., Steain, M., Fong, Y., Gilbert, P. B., Subbarao, K., Triccas, J. A., Kent, S. J., Davenport, M. P.
10.1101/2022.06.05.22275943 — Posted: 2022-06-06
Does place connectivity moderate the association between concentrated disadvantage and COVID-19 fatality in the United States?
Jing, F., Li, Z., Qiao, S., Zhang, J., Olatosi, B., Li, X.
10.1101/2022.06.06.22276053 — Posted: 2022-06-06
On the origin of Omicron's unique Spike gene insertion
Venkatakrishnan, A., Anand, P., Lenehan, P. J., Suratekar, R., Raghunathan, B., Niesen, M. J., Soundararajan, V.
10.1101/2022.06.03.22275976 — Posted: 2022-06-06
Persistence of immunity against omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination
Assawakosri, S., Kanokudom, S., Chansaenroj, J., Suntronwong, N., Auphimai, C., Nilyanimit, P., Vichaiwattana, P., Thongmee, T., Duangchinda, T., Chantima, W., Pakchotanon, P., Srimuan, D., Thatsanatorn, T., Klinfueng, S., Sudhinaraset, N., Wanlapakorn, N., Mongkolsapaya, J., Honsawek, S., Poovorawan, Y.
10.1101/2022.06.05.22276016 — Posted: 2022-06-06
Understanding COVID-19 admissions in the UK; Analysis of Freedom of Information Requests
Jefferson, T., Brassey, J., Heneghan, C.
10.1101/2022.06.06.22276032 — Posted: 2022-06-06
Predictors of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses: a cross-sectional study
Galanis, P. A., Vraka, I., Katsiroumpa, A., Siskou, O., Konstantakopoulou, O., Katsoulas, T., Mariolis-Sapsakos, T., Kaitelidou, D.
10.1101/2022.06.04.22275989 — Posted: 2022-06-06
Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP
Hulme, W. J., Williamson, E. J., Horne, E., Green, A. C., Nab, L., Keogh, R., Parker, E. P., Walker, V. M., Palmer, T. M., Curtis, H. J., Wiedemann, M., Cunningham, C., Walker, A. J., Fisher, L., MacKenna, B., Rentsch, C. T., Schultze, A., Bhaskaran, K., Tazare, J., Tomlinson, L. A., McDonald, H. I., Morton, C. E., Croker, R., Andrews, C. D., Hopcroft, L. E., Park, R. Y., Massey, J., Mehrkar, A., Morley, J., Bacon, S. C., Evans, D., Inglesby, P., Hickman, G., Davy, S., Dillingham, I., Ward, T., Mahalingasivam, V., Zheng, B., Douglas, I. J., Evans, S. J., Bates, C., Sterne, J. A., Hernan, M. A., Goldacre, B.
10.1101/2022.06.06.22276026 — Posted: 2022-06-06
Development and application of an uncapped mRNA platform
Liu, B., Ni, P., Cai, L., Shi, X., Ji, S., Ke, Z., Zhang, S., Hu, B., Yang, B., Xu, Y., Long, W., Fang, Z., Hu, H., Wang, Y., Zhang, W., Geng, H., Xu, Y., Zheng, X., Wang, Z., Zhang, B., Pan, K., Zhou, K., Cui, Y., Wang, H., Liu, B.
10.1101/2022.06.05.494796 — Posted: 2022-06-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).